SN

Susmita Nandi

Active Director Designated Partner DIN 10125919
DIN 10125919 First appointment Apr 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Susmita Nandi

Data last updated:

Susmita Nandi is a Designated Partner at Synsys Chemicals And Pharmaceutical Llp (since 2023). The company operates in Pharma.

DIN 10125919
Primary Designation Designated Partner
Industry Pharma
First Appointment 20 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Apr 20232023Active

Board colleagues of Susmita Nandi

NameDINCompanyDesignation
Debashish Datta08810026Synsys Chemicals And Pharmaceutical LlpDesignated Partner
Snigdha Gupta10125920Synsys Chemicals And Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Synsys Chemicals And Pharmaceutical Llp
Premium access

Shareholding and investment profile for Susmita Nandi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Susmita Nandi

Susmita Nandi currently holds 1 directorship: Synsys Chemicals And Pharmaceutical Llp (Designated Partner, since 20 Apr 2023).

Susmita Nandi was first appointed on 20 Apr 2023 as Designated Partner at Synsys Chemicals And Pharmaceutical Llp.

The current boards of Susmita Nandi's companies include Debashish Datta (Synsys Chemicals And Pharmaceutical Llp), Snigdha Gupta (Synsys Chemicals And Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available